OFFICES IN Washington D.C. & New Delhi

Center For Disease Dynamics, Economics & Policy

Board of Directors

The Board of Directors of Center for Disease Dynamics, Economics & Policy is comprised of individuals representing the business community, public health organizations, former policymakers, as well as pre-eminent scholars. The board provides overall direction for the organization and meets twice annually. Members are eligible to serve for three three-year terms.

CDDEP is deeply committed to bringing to the board, in ever-greater numbers, leading figures from outside the United States as well as representatives of minority populations from North America.

Professional affiliations of board members are listed for identification purposes only.


Anil Deolalikar
Dean of the School of Public Policy
University of California, Riverside

Susan M. Fitzpatrick
James S. McDonnell Foundation (JSMF)

Ramanan Laxminarayan
Center for Disease Dynamics, Economics & Policy

Didier Pittet
Infection Control Programme & WHO Collaborating Centre on Patient Safety
The University of Geneva Hospitals and Faculty of Medicine
Geneva, Switzerland

Stephen Tollman
MRC/Wits Rural Public Health and Health Transitions Research Unit Head,
Health & Population Division, School of Public Health
University of the Witwatersrand
Johannesburg, South Africa

Mary E. Wilson
Clinical Professor of Epidemiology and Biostatistics
University of California, San Francisco

Indu Bhushan
Founding CEO of Ayushman Bharat- Pradhan Mantri Jan Arogya Yohana (AB- PMJAY)


Ramanan Laxminarayan, Director

Ramanan Laxminarayan directs the Center for Disease Dynamics, Economics & Policy.  He is also a visiting scholar and lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding of drug resistance as a problem of managing a shared global resource.

Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. From 2003 to 2004, he served on the National Academy of Science/Institute of Medicine Committee on the Economics of Antimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC, NPR, Reuters, Science, Wall Street Journal, and National Journal.


Anil Deolalikar

Anil Deolalikar is a Professor of Economics and Founding Dean of the School of Public Policy at the University of California, Riverside. He also serves as the Chair of the Board of Directors of the University of California Global Health Institute. He taught previously at the University of Washington, University of Pennsylvania, and Harvard University, and served as Lead Human Development Economist for the World Bank in India during 2002-03.

Deolalikar is a development economist who has published five books and nearly 75 articles on the economics of child nutrition, health, education, poverty, and social protection in developing countries.

He is co-editor of The Journal of Asian and African Studies and The Journal of Developing Societies. He is a Fellow of the American Association for the Advancement of Science. He was also a recipient of the Robert McNamara Fellowship for International Development awarded by the World Bank.

Deolalikar has served as a consultant to a number of developing-country governments and international organizations, including the ADB, World Bank, UNDP, and USAID, on a variety of research and policy projects.

He obtained his BA summa cum laude in economics from Harvard University, Diploma in Economics from Cambridge University, Ph.D. from Stanford University, and a Postdoctoral Fellowship in Economic Demography from Yale University.


Susan M. Fitzpatrick

Susan M. Fitzpatrick (Ph.D.) is an Adjunct Associate Professor of Neuroscience and Occupational Therapy at Washington University School of Medicine and is a volunteer faculty member at the Center for Biology and Society, School of Life Sciences at Arizona State University. She is an elected Fellow of the Association for the Advancement of Science and the Association for Women in Science. Dr. Fitzpatrick lectures and writes on issues concerning applications of neuroscience to clinical problems, the translation of cognitive science to educational settings, the role of private philanthropy in the support of scientific research, and issues related to the public dissemination of and understanding of science.

She is President and CEO of the James S. McDonnell Foundation (JSMF) since 2015 but has worked with the foundation in different roles since 1993. She serves on the boards of the Ontario Brain Institute, the Missouri Science and Technology Fellows Program, and Dr. Fitzpatrick is a member of the Science Board of the Santa Fe Institute and is on the Advisory Council for the Institute for Neuroscience and Neurotechnology at Simon Fraser University.

With her Ph.D. in Biochemistry and Neurology from Cornell University Medical College (1984), she pursued post-doctoral training with in vivo NMR spectroscopic studies of brain metabolism/function in the Department of Molecular Biochemistry and Biophysics at Yale University.

Dr. Fitzpatrick served as the Associate Executive Director of the Miami Project to Cure Paralysis (1989-1992), as Executive Director of the Brain Trauma Foundation (1992-1993), and is a past member of the board of the American Association for the Advancement of Science, the American Occupational Therapy Foundation, and Research!America. She is a former President and Chair of the Board of the Association for Women in Science and has served as a member of the International Advisory Council of the Rotman Institute for Philosophy.


Didier Pittet

Didier Pittet, MD, MS, is a Professor of Medicine, a Hospital Epidemiologist, and the Director of the Infection Control Programme and World Health Organization (WHO) Collaborating Centre on Patient Safety at the University of Geneva Hospitals and Faculty of Medicine, Geneva, Switzerland. He holds honorary professorships at Imperial College London, UK; Hong Kong Polytechnic University School of Health Science; and the First Medical School of the Fu, Shanghai, China. He is a Fellow of the Royal Society of Medicine, Ireland and an honorary member of All-Russian Scientific Societies of Epidemiologists, Microbiologists, and Parasitologists. Professor Pittet is the Lead Advisor for the WHO “Saves Lives: Clean Your Hands campaign”, active in more than 180 of the 194 UN member states.

Professor Pittet is the recipient of several national and international honors, including a CBE (Commander of the British Empire) awarded by Her Majesty Queen Elisabeth II for services in the prevention of healthcare-associated infection in the UK (2007); the Society for Healthcare Epidemiology of America Lectureship for his contribution to infection control and healthcare epidemiology (2008); the European Society of Clinical Microbiology and Infectious Diseases’ Award for Excellence (2009); the American Society for Microbiology (ASM/ICAAC 2016); and the Robert Koch award (2017). The book “Clean Hands Save Lives” by the French writer Thierry Crouzet (Editions L’Âge d’Homme, 2014), published in 18 languages (2017), and the movie “Clean Hands” (AFTERMEDIA, 2016), describe Didier Pittet’s medical odyssey to promote patient safety worldwide.

Professor Pittet is co-author of more than 500 publications in peer-reviewed journals and 50 textbook chapters. He is the editor of the textbook “Hand Hygiene – A Handbook for Medical Professionals” (Pittet, Boyce, Allegranzi, Wiley-Blackwell, 2017). Professor Pittet serves on the editorial boards of several journals and is an editorial consultant for the Lancet. Professor Pittet has delivered a large number of plenary/opening lectures at many major meetings/congresses in the field of infectious diseases/infection control/patient safety. He is recognized as a fascinating and very engaging speaker. Professor Pittet’s current research interests include the epidemiology and prevention of healthcare-associated infections, methods for improving compliance with barrier precautions and hand hygiene practices, as well as innovative methods for improving patient care and safety. He is also involved in research on the epidemiology of infectious diseases and public and global health issues. The experience of his team in engaging nations and healthcare settings worldwide with a universal commitment to patient safety is unique.


Stephen Tollman

Steve Tollman (BSc, MMed, MA, MPH, Ph.D.) directs the MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt) and the Health and Population Division in the School of Public Health, University of the Witwatersrand. Internationally, he is a guest professor at the Centre for Global Health Research, Umeå University, Sweden, and Principal Scientist for the INDEPTH Network (International Network for the Demographic Evaluation of Populations and Their Health).

In 1979 he graduated from Wits University with a BSc in Anatomy and Physiology.  He continued his studies at Wits obtaining his Bachelor of Medicine and Bachelor of Surgery degree in 1984, and a Master of Medicine in 1999. Further studies took him to Oxford University and Harvard University culminating in a Ph.D. in Public Health and Epidemiology from Umeå University, Sweden.

Steve was the founding Board Chair of INDEPTH and is a principal investigator for multi-center research into Adult Health and Aging.  He serves on several fellowship and grant review panels. His ongoing commission participation includes Migration and Health (UCL-Lancet); Global challenge of multimorbidity (Academy of Sciences, UK), and Continuing epidemiological transition in sub-Saharan Africa  (National Academies of Science, USA).

His major research interests include adult health and aging, cardiometabolic disease, and chronic care.


Mary E. Wilson

Mary E. Wilson, M.D. is a Clinical Professor of Epidemiology and Biostatistics at the University of California, San Francisco, and Adjunct Professor of Global Health and Population, at Harvard T.H. Chan School of Public Health. She received her MD from the University of Wisconsin and is board certified in internal medicine and infectious diseases (residency and fellowship at Beth Israel Hospital in Boston). Her academic interests include antibiotic resistance, the ecology of infections and the emergence of microbial threats, travel medicine, tuberculosis, and vaccines.

She is Vice-Chair of the Forum on Microbial Threats at the National Academies of Science, Engineering, and Medicine. She is a fellow in the Infectious Diseases Society of America, the American College of Physicians, the American Society of Tropical Medicine and Hygiene, and the International Society of Travel Medicine. She has served on the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention, the Academic Advisory Committee for the National Institute of Public Health in Mexico, and on five committees for the National Academies of Sciences, Engineering, and Medicine.

Dr. Wilson was a member of the Pew National Commission on Industrial Farm Animal Production, whose report, “Putting Meat on the Table: Industrial Farm Animal Production in America”, was released in the spring of 2008. She is the author of “A World Guide to Infections: Diseases, Distribution, Diagnosis” (Oxford University Press, 1991). She was the senior editor, with Richard Levins and Andrew Spielman, of “Disease in Evolution: Global Changes and Emergence of Infectious Diseases” (NY Academy of Sciences, 1994). Dr. Wilson was the editor of “New and Emerging Infectious Diseases” (Medical Clinics of North America) and the author of “Antibiotics: What Everyone Needs to Know” (Oxford University Press, 2019). She is one of the medical editors for the CDC’s “Health Information for International Travel” (Yellow Book); she serves as an advisor to the GeoSentinel Surveillance Network’ and is an associate editor for NEJM Journal Watch Infectious Diseases. She has served on several boards and advisory committees, including the Board of Trustees for ICCDRB in Bangladesh for 6 years. She is a member of the Advisory Board for the Fogarty International Center at NIH as well.


Indu Bhushan

Indu Bhushan, Ph.D., has a career spanning almost 40 years across a multitude of sectors. He began his career in the  Indian government (Rajasthan State), where he served for nine years as an Indian Administrative Service officer, a highly coveted role in India. Thereafter, he worked as a Senior Economist with the World Bank Group before moving to the Asian Development Bank (ADB) in 1997. 

He served as Director General of the East Asia Department of ADB and held multiple positions within ADB, including Director General of the Strategy and Policy Department. He led ADB’s engagement with several Asian economies including the People’s Republic of China and he provided oversight to sectors, including the energy, environment, natural resources, agriculture, transport, public management, financial and regional cooperation, and urban and social development sectors.   

In 2018, Dr. Bhushan was appointed the Chief Executive Officer (CEO) of Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB – PMJAY), a flagship health assurance scheme of the Indian government, covering more than 500 million citizens. As the founding CEO, he led the design, development, and rollout of the scheme, and oversaw its implementation in the country. He also initiated the implementation of the ambitious National Digital Health Mission (later renamed Ayushman Bharat Digital Mission). 

Dr. Bhushan holds a Ph.D. in Health Economics and a Master of Health Sciences from Johns Hopkins University, USA. He is an alumnus of the Indian Institute of Technology Banaras Hindu University (IIT BHU) and IIT Delhi, where he completed his B. Tech and Post Graduate Diploma, respectively. He is also a Chartered Financial Analyst (CFA).